Free Trial

Avanos Medical (AVNS) Earnings Date, Estimates & Call Transcripts

Avanos Medical logo
$12.42 -0.05 (-0.40%)
As of 04/14/2025 03:58 PM Eastern

Avanos Medical Earnings Summary

Upcoming
Earnings Date
May. 1Before Market OpensEstimated
Consensus EPS
(Feb. 26)
$0.40
Actual EPS
(Feb. 26)
$0.43 Beat By $0.03
Actual Revenue
(Feb. 26)
$179.60M

Avanos Medical issued Q4 2024 earnings on February 26, 2025, reporting an EPS of $0.43, which topped the consensus estimate of $0.40 by $0.03. Quarterly revenue was reported to be $179.60 million, above analysts' expectations of $177.23 million. With a trailing EPS of -$8.53 and a P/E Ratio of 36.53, Avanos Medical's earnings are expected to grow 31.06% next year, from $1.32 to $1.73 per share.

Q4 2024 Earnings Resources

AVNS Upcoming Earnings

Avanos Medical's Q1 2025 earnings is scheduled for Thursday, May 1, 2025, with a conference call scheduled at 9:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Avanos Medical Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avanos Medical and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

AVNS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AVNS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

Avanos Medical Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20251$0.19$0.19$0.19 
Q2 20251$0.29$0.29$0.29 
Q3 20251$0.30$0.30$0.30 
Q4 20251$0.42$0.42$0.42 
FY 20254$1.20$1.20$1.20 
Q1 20261$0.31$0.31$0.31 
Q2 20261$0.30$0.30$0.30 
Q3 20261$0.39$0.39$0.39 
Q4 20261$0.49$0.49$0.49 
FY 20264$1.49$1.49 $1.49
Remove Ads

Avanos Medical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/1/2025
(Estimated)
-------
2/26/2025Q4 2024$0.40$0.43+$0.03-$8.64$177.23M$179.60M
7/31/2024Q2 2024$0.29$0.34+$0.05$0.64$170.67M$171.70M
5/2/2024Q1 2024$0.21$0.19 -$0.02$0.40$162.90M$166.10M
2/20/2024Q4 2023$0.37$0.36 -$0.01$0.49$170.43M$173.30M
11/1/2023Q3 2023$0.29$0.30+$0.01$0.68$169.60M$171.30M
8/9/2023Q2 2023$0.34$0.24 -$0.10$1.94$186.30M$169.40M
5/3/2023Q1 2023$0.28$0.27 -$0.01$0.55$195.20M$191.70M

Avanos Medical Earnings - Frequently Asked Questions

Avanos Medical has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 1st, 2025 based off last year's report dates. Learn more on AVNS's earnings history.

Avanos Medical updated its FY 2025 earnings guidance on Wednesday, February, 26th. The company provided earnings per share guidance of 1.050-1.250 for the period, compared to the consensus earnings per share estimate of 1.670. The company issued revenue guidance of $665.0 million-$685.0 million, compared to the consensus revenue estimate of $713.1 million.

In the previous quarter, Avanos Medical (NYSE:AVNS) reported $0.43 earnings per share (EPS) to beat the analysts' consensus estimate of $0.40 by $0.03. Learn more on analysts' earnings estimate vs. AVNS's actual earnings.

The conference call for Avanos Medical's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Avanos Medical's latest earnings report can be read online.
Read Transcript

Avanos Medical (NYSE:AVNS) has a recorded annual revenue of $687.80 million.

Avanos Medical (NYSE:AVNS) has a recorded net income of -$61.80 million. AVNS has generated -$8.53 earnings per share over the last four quarters.

Avanos Medical (NYSE:AVNS) has a trailing price-to-earnings ratio of 36.53 and a forward price-to-earnings ratio of 9.41.

Avanos Medical's earnings are expected to grow from $1.32 per share to $1.73 per share in the next year, which is a 31.06% increase.

More Earnings Resources from MarketBeat

Remove Ads


This page (NYSE:AVNS) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners